Aarti Drugs Ltd. Publishes Notice on Transfer of Equity Shares to IEPF Account
Aarti Drugs Limited published a notice on June 16, 2026, regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Account. This is in compliance with the Companies Act, 2013 and IEPF Rules. The notice appeared in Financial Express and Pratahkal.
This is a routine compliance filing related to unclaimed shares and does not have a direct, material impact on the company's operational performance, financial results, or stock valuation.
The announcement is a routine regulatory filing regarding the transfer of shares to the IEPF account, which is a standard compliance procedure and does not inherently indicate positive or negative financial performance or business operations.
Aarti Drugs Limited has submitted copies of a notice to its equity shareholders regarding the transfer of their shares to the Investor Education and Protection Fund (IEPF) Account. This action is in compliance with Section 124(6) of the Companies Act, 2013, and the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The notice was published on Tuesday, June 16, 2026, in two newspapers: The Financial Express (English) and Pratahkal (Marathi).
The company has informed the stock exchanges, BSE Limited and the National Stock Exchange of India Limited, about this submission. Rushikesh Deole, Company Secretary & Compliance Officer, signed the communication.
What to do with a filing like this
Aarti Drugs Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Drugs Limited. Read the original for the full detail.